Literature DB >> 20969482

Identification of three immunologic correlates for HIV type 1 pathogenesis in youth.

Wei Song1, Yufeng Li, Craig M Wilson, Jianming Tang.   

Abstract

To evaluate the stability and heterogeneity of cytokine and chemokine profiles in 80 youth with and without HIV-1 infection, we tested plasma samples at repeated visits without antiretroviral therapy. Among nine analytes that were quantified using multiplexing assays, interleukin 10 (IL-10), IL-18, and soluble CD30 persistently showed a positive correlation with HIV-1 viral load (Spearman ρ = 0.40-0.59, p < 0.01 for all). A negative correlation with CD4(+) T cell counts (ρ = -0.40 to -0.60, p < 0.01 for all) was also persistent for the three analytes. Analyses restricted to 48 AIDS-free youth (96 visits) yielded similar findings, as did multivariable models in which race, sex, age, body mass index, and time interval between visits were treated as covariates. These relationships reflected two novel features observed for all three analytes. First, their presence in plasma was relatively stable between visits (ρ = 0.50-0.90, p < 0.03), regardless of HIV-1 infection status. Second, pairwise correlation was strong and persistent in HIV-1-seropositive youth (ρ = 0.40-0.59, p < 0.01), but not in HIV-1, seronegatives (p > 0.13). Additional analytes, especially eotaxin/CCL11 and SDF-1β/CXCL12, had no correlation with HIV-1-related outcomes despite their stability between visits. Overall, circulating IL-10, IL-18, and soluble CD30 could partially track unfavorable responses to HIV-1 infection in youth. These markers of persistent immune activation are individually and collectively indicative of HIV-1 pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20969482      PMCID: PMC3101082          DOI: 10.1089/AID.2010.0161

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  64 in total

1.  Interleukin-4 up-regulates T-tropic human immunodeficiency virus type 1 transcription in primary CD4+ CD38+ T-lymphocyte subset.

Authors:  Yong-Gang Li; Yukie Iwabu; Jiranan Warachit; Masanobu Kinomoto; Madiha S Ibrahim; Shoutaro Tsuji; Tetsu Mukai; Masanori Kameoka; Kenzo Tokunaga; Tetsutaro Sata; Kazuyoshi Ikuta
Journal:  Microbiol Immunol       Date:  2005       Impact factor: 1.955

2.  Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction.

Authors:  Lydie Trautmann; Loury Janbazian; Nicolas Chomont; Elias A Said; Sylvain Gimmig; Benoit Bessette; Mohamed-Rachid Boulassel; Eric Delwart; Homero Sepulveda; Robert S Balderas; Jean-Pierre Routy; Elias K Haddad; Rafick-Pierre Sekaly
Journal:  Nat Med       Date:  2006-08-20       Impact factor: 53.440

3.  PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression.

Authors:  Cheryl L Day; Daniel E Kaufmann; Photini Kiepiela; Julia A Brown; Eshia S Moodley; Sharon Reddy; Elizabeth W Mackey; Joseph D Miller; Alasdair J Leslie; Chantal DePierres; Zenele Mncube; Jaikumar Duraiswamy; Baogong Zhu; Quentin Eichbaum; Marcus Altfeld; E John Wherry; Hoosen M Coovadia; Philip J R Goulder; Paul Klenerman; Rafi Ahmed; Gordon J Freeman; Bruce D Walker
Journal:  Nature       Date:  2006-08-20       Impact factor: 49.962

4.  Neonatal natural killer cells produce chemokines and suppress HIV replication in vitro.

Authors:  Helene B Bernstein; Audrey L Kinter; Robert Jackson; Anthony S Fauci
Journal:  AIDS Res Hum Retroviruses       Date:  2004-11       Impact factor: 2.205

5.  Immune reconstitution and predictors of virologic failure in adolescents infected through risk behaviors and initiating HAART: week 60 results from the PACTG 381 cohort.

Authors:  Bret J Rudy; Jane C Lindsey; Patricia M Flynn; Ronald J Bosch; Craig M Wilson; Michael E Hughes; Steven D Douglas
Journal:  AIDS Res Hum Retroviruses       Date:  2006-03       Impact factor: 2.205

6.  Interleukin 18 and human immunodeficiency virus type I infection in adolescents and adults.

Authors:  W Song; C M Wilson; S Allen; C Wang; Y Li; R A Kaslow; J Tang
Journal:  Clin Exp Immunol       Date:  2006-04       Impact factor: 4.330

7.  HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells.

Authors:  Michael R Betts; Martha C Nason; Sadie M West; Stephen C De Rosa; Stephen A Migueles; Jonathan Abraham; Michael M Lederman; Jose M Benito; Paul A Goepfert; Mark Connors; Mario Roederer; Richard A Koup
Journal:  Blood       Date:  2006-02-07       Impact factor: 22.113

8.  PD-1 is a regulator of virus-specific CD8+ T cell survival in HIV infection.

Authors:  Constantinos Petrovas; Joseph P Casazza; Jason M Brenchley; David A Price; Emma Gostick; William C Adams; Melissa L Precopio; Timothy Schacker; Mario Roederer; Daniel C Douek; Richard A Koup
Journal:  J Exp Med       Date:  2006-09-05       Impact factor: 14.307

9.  Maintenance of viral suppression in HIV-1-infected HLA-B*57+ elite suppressors despite CTL escape mutations.

Authors:  Justin R Bailey; Thomas M Williams; Robert F Siliciano; Joel N Blankson
Journal:  J Exp Med       Date:  2006-05-08       Impact factor: 14.307

Review 10.  Reinvigorating exhausted HIV-specific T cells via PD-1-PD-1 ligand blockade.

Authors:  Gordon J Freeman; E John Wherry; Rafi Ahmed; Arlene H Sharpe
Journal:  J Exp Med       Date:  2006-09-25       Impact factor: 14.307

View more
  4 in total

1.  Cytokines Elevated in HIV Elite Controllers Reduce HIV Replication In Vitro and Modulate HIV Restriction Factor Expression.

Authors:  Evan S Jacobs; Sheila M Keating; Mohamed Abdel-Mohsen; Stuart L Gibb; John W Heitman; Heather C Inglis; Jeffrey N Martin; Jinbing Zhang; Zhanna Kaidarova; Xutao Deng; Shiquan Wu; Kathryn Anastos; Howard Crystal; Maria C Villacres; Mary Young; Ruth M Greenblatt; Alan L Landay; Stephen J Gange; Steven G Deeks; Elizabeth T Golub; Satish K Pillai; Philip J Norris
Journal:  J Virol       Date:  2017-02-28       Impact factor: 5.103

2.  Design and analysis of rhesus cytomegalovirus IL-10 mutants as a model for novel vaccines against human cytomegalovirus.

Authors:  Naomi J Logsdon; Meghan K Eberhardt; Christopher E Allen; Peter A Barry; Mark R Walter
Journal:  PLoS One       Date:  2011-11-21       Impact factor: 3.240

3.  Effect of MHC haplotype on immune response upon experimental SHIVSF162P4cy infection of Mauritian cynomolgus macaques.

Authors:  Alessandra Borsetti; Flavia Ferrantelli; Maria T Maggiorella; Leonardo Sernicola; Stefania Bellino; Alessandra Gallinaro; Stefania Farcomeni; Edward T Mee; Nicola J Rose; Aurelio Cafaro; Fausto Titti; Barbara Ensoli
Journal:  PLoS One       Date:  2014-04-02       Impact factor: 3.240

4.  High Plasma Levels of sTNF-R1 and CCL11 Are Related to CD4+ T-Cells Fall in Human Immunodeficiency Virus Elite Controllers With a Sustained Virologic Control.

Authors:  Mónica Gutiérrez-Rivas; María Ángeles Jiménez-Sousa; Norma Rallón; José Luis Jiménez; Clara Restrepo; Agathe León; Marta Montero-Alonso; Juan González-García; María Ángeles Muñoz-Fernández; José Miguel Benito; Salvador Resino
Journal:  Front Immunol       Date:  2018-06-18       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.